The SEC filed insider trading charges against two individuals for illegally profiting off advance knowledge of a study conducted by Pfizer on their COVID-19 treatment, Paxlovid.
The SEC and U.S. Attorney’s Office filed insider trading charges against Bruce Garelick, Michael Shvartsman, Gerald Shvartsman, and Rocket One Capital LLC for illegally profiting over $22 million from trading in advance of a DWAC announcement.
The SEC has filed a settled complaint charging MusclePharm Corp.'s former Executive Vice President of Sales and Operations, Brian H. Casutto, former Vice President of Sales, Matthew J. Zucco, and former contract Chief Financial Officer, Kevin R. Harris, for engaging in improper revenue recognition practices, while the SEC separately charged former Chief Executive Officer, Ryan C. Drexler, with fraud in a litigated complaint.
The SEC has charged Jordan Meadow, a broker-dealer, and Steven Teixeira, a compliance officer, with insider trading based on material nonpublic information obtained from his girlfriend's laptop during the COVID-19 pandemic.
The SEC today filed insider trading charges against five individuals, including a police chief in Massachusetts, for misusing confidential information to make more than $2.3 million in ill-gotten gains.
The SEC announced settled charges against View Inc., a California-based manufacturer of “smart” windows, and filed charges against the company's former CFO for failing to disclose $28 million in warranty-related liabilities.